|
CVD
|
cardiovascular disease
|
|
DAG
|
diacyl glycerol
|
|
DALY
|
disability‐adjusted life‐years
|
|
DC
|
direct calorimetry
|
|
DIT
|
diet‐induced thermogenesis
|
|
DOHaD
|
developmental origins of health and disease
|
|
DEXA
|
dual‐energy X‐ray absorptiometry
|
|
EB
|
energy balance
|
|
EBM
|
evidence‐based medicine
|
|
ED
|
erectile dysfunction
|
|
EDS
|
excessive daytime sleepiness
|
|
EE
|
energy expenditure
|
|
EI
|
energy intake
|
|
EMCL
|
extramyocellular lipid
|
|
EMG
|
electromyogram
|
|
EMR
|
electronic medical record
|
|
EOG
|
electro‐oculogram
|
|
EPOC
|
postexercise oxygen consumption
|
|
FABP
|
fatty acid binding proteins
|
|
FDG‐PET
|
fluorodeoxyglucose positron emission tomography
|
|
FFA
|
free fatty acids
|
|
FFM
|
fat‐free mass
|
|
FFQ
|
food frequency questionnaire
|
|
fMRI
|
functional magnetic resonance imaging
|
|
GERD
|
gastroesophageal reflux disease
|
|
GDM
|
gestational diabetes
|
|
GH
|
growth hormone
|
|
GHD
|
growth hormone deficiency
|
|
GHS‐R1a
|
growth hormone secretagog receptor 1a
|
|
GI
|
gastrointestinal; Glycemic Index
|
|
GIP
|
gastric inhibitory peptide
|
|
GL
|
glycemic load
|
|
GLP‐1
|
glucagon‐like peptide‐1
|
|
GLUT‐4
|
glucose transporter‐4 CER ceramide
|
|
HCC
|
hepatocellular carcinoma
|
|
HCG
|
human chorionic gonadotropin
|
|
HD
|
hydrodensitometry
|
|
HDL
|
High‐density lipoprotein
|
|
HB‐EGF
|
heparin‐binding epidermal growth factor like growth factor
|
|
HF
|
heart failure
|
|
HSL
|
hormone‐sensitive lipase
|
|
IAPP
|
islet amyloid polypeptide
|
|
IBW
|
ideal body weight
|
|
IC
|
indirect calorimetry
|
|
IDF
|
International Diabetes Federation
|
|
IGT
|
impaired glucose tolerance
|
|
IHD
|
ischemic heart disease
|
|
IMCL
|
intramyocellular lipid
|
|
IOTF
|
International Obesity Task Force
|
|
IRS
|
insulin receptor substrates
|
|
IUGR
|
intrauterine growth restriction
|
|
IVF
|
in vitro fertilization
|
|
JIB
|
jejunoileal bypass
|
|
KO
|
knockout
|
|
LAGB
|
laparoscopic adjustable gastric banding
|
|
LAUP
|
laser‐assisted uvulopalatoplasty
|
|
LDL
|
low‐density lipoprotein
|
|
LBM
|
lean body mass
|
|
LED
|
low‐energy diets
|
|
LH
|
lateral hypothalamic; luteinizing hormone
|
|
LPL
|
lipoprotein lipase
|
|
LV
|
left ventricular
|
|
MACE
|
major adverse cardiac event
|
|
MAD
|
mandibular advancement devices
|
|
MAFLD
|
metabolic dysfunction‐associated fatty liver disease
|
|
MAS
|
McCune–Albright syndrome
|
|
MC4R
|
melanocortin concentrating hormone receptor 4
|
|
MCH
|
melanin‐concentrating hormone
|
|
MCP‐1
|
|
